Rhetsinine is an aldose reductase inhibitor identified in Evodia rutaecarpa, with an IC50 value of 24.1 μM. At a concentration of 100 μM, Rhetsinine significantly reduces sorbitol accumulation, achieving an inhibition rate of 79.3%. This compound is applicable in research concerning diabetic complications, such as diabetic neuropathy and retinopathy.